Abstract
Background: Intramyocardial injection of human CD34+ cells may improve outcomes in patients with chronic refractory angina not amenable to revascularization or standard medical therapy. We performed a meta-analysis to evaluate the effect of this therapy in patients with refractory angina. Methods:
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
